Skip to main content
. 2022 Nov 25;12(11):e067838. doi: 10.1136/bmjopen-2022-067838

Table 3.

Baseline characteristics of the training and validation group

Training group (n=8129) Validation group (n=3469) P value
Outcomes 0.610
 LFR 230 (2.8) 88 (2.5)
 TFF 256 (3.1) 104 (3.0)
Baseline characteristics
 Age, mean (SD) 31.8 (4.7) 31.8 (4.7) 0.688
 BMI (kg/m2), mean (SD) 22.0 (3.5) 22.1 (3.1) 0.387
 Infertility years, mean (SD) 3.8 (3.1) 3.9 (3.2) 0.013
 Infertility diagnosis, n (%) 0.050
  Tubal factor 5804 (71.4) 2472 (71.3)
  Diminished ovarian reserve 854 (10.5) 383 (11.0)
  Ovulatory dysfunction 158 (1.9) 78 (2.2)
  Uterine factor 226 (2.8) 109 (3.1)
  Sperm factor 554 (6.8) 187 (5.4)
  Unexplained infertility 533 (6.6) 240 (6.9)
 Primary infertility, n (%) 3582 (44.1) 1478 (42.6) 0.147
 Gravidity, n (%) 0.297
  0 3220 (39.6) 1334 (38.5)
  1 2069 (25.5) 928 (26.8)
  ≥2 2840 (34.9) 1207 (34.8)
 Parity, n (%) 0.131
  0 6827 (84.0) 2952 (85.1)
  ≥1 1302 (16.0) 517 (14.9)
 Induced abortion, n (%) 2630 (32.4) 1140 (32.9) 0.592
 Miscarriage, n (%) 1157 (14.2) 502 (14.5) 0.737
 Basal FSH (mIU/mL), mean (SD) 8.3 (3.3) 8.4 (3.6) 0.241
 Basal LH (mIU/mL), mean (SD) 4.5 (3.3) 4.6 (3.5) 0.261
 AMH (ng/mL), mean (SD) 3.2 (2.4) 3.2 (2.4) 0.951
 AFC, mean (SD) 13.5 (7.7) 13.3 (7.7) 0.350

Continuous variables are expressed as mean (SD), categorical variables as absolute frequencies, n (%).

AFC, antral follicle count; AMH, anti-Müllerian hormone; BMI, body mass index; FSH, follicular-stimulating hormone; LFR, low fertilisation rate; LH, luteinising hormone; TFF, total fertilisation failure.